Keyword: Axplora

Chemistry & Life Sciences

The Evolution of the CDMO Industry

11.09.2024 -

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine...

Chemistry & Life Sciences

Expert Statement: Martin Meeson, Axplora

02.09.2024 -

The evolution of the CDMO sector is propelled by rising manufacturing standards, the advent of groundbreaking therapies, and a shift towards personalized medicine.

News

Axplora’s Farmabios Gets cGMP Approval for New Production Unit in Italy

10.10.2023 -

Farmabios, a company of the Axplora group founded in 2022, has received the cGMP approval from AIFA (national public body regulating medicines for human use in Italy) for...

News

Axplora Opens cGMP Pilot Plant for Flow Chemistry in Leverkusen

25.07.2023 -

Axplora has completed the installation of a new cGMP (cyclic guanosine monophosphate) pilot unit at its German site in Leverkusen, costing more than €1 million.

Research & Innovation

Axplora Aims to Make Pharmaceutical Supply Chains More Stable

22.02.2023 -

Interview with Sylke Hassel, previous CEO of PharmaZell and current CEO of Axplora following the merger with Novasep.

News

Flow Chemistry

07.12.2022 -

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this...

News

Flow Chemistry

28.11.2022 -

Executives and industry experts share their views on drivers as well as barriers for the use of flow chemistry in pharmaceutical manufacturing and the prospect for this...

News

Farmabios, Novasep and PharmaZell now Axplora

21.10.2022 -

Following the merger of French CDMO Novasep and German API maker PharmaZell in April this year, all brands of the two companies, including those of PharmaZell’s group...